Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias?

Samy Suissa, Deborah Assayag

Source: Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020
Journal Issue: March
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Samy Suissa, Deborah Assayag. Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias?. Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Teresa Lawrence - 21.12.2021 10:28
It’s difficult not knowing what the next day will bring. To anyone who’s just been diagnosed with IPF, or another long-term lung condition, I’d say live life to the full and take all the help you can get. It can be difficult to talk to your family and friends about what you’re going through, but it’s important to make sure they understand what’s happening and how you’re feeling. I was cured naturally with the use of Dr Gomez Sims RSO Cannabis Oil, within a period of 3 weeks, I was recovering, It’s also crucial to learn as much as you can about your diagnosis. Seek options. Find out about what’s out there that could help. Contact Dr Odia via email:( drodiaherbalistcenter@gmail.com ) or ( WhatsApp +17278553511 ) or visit www.facebook.com/DrOdiathenaturopathic/
You must Login to comment this presentation.


Related content which might interest you: